Skip to content

EQUIPHARMA

Inactive
Private limited companyKBO/BCE: BE 0475.932.379

Inactive since 12-08-2026; last annual accounts for financial year 2025. Dissolved and wound up in a single deed; no liquidator appointed.

EQUIPHARMAInactive

Overview

Activity
“De aankoop en verkoop van farmaceutische producten van schoonheidsproducten en aanverwante producten” (deed in Dutch)
From the articles, 7 activitiesNo NACE code in the KBO yet
Size
≈ €260,000turnover 2025, estimated
Equity
-€75,256
Profit
€82,111
Turnover estimated from the gross margin
Financial health
Inactive: no score
Structure
3 of 4 deeds summarised
SignalsneutralLatest accounts filed on timeShow the evidence

Signals

1 signal.
neutral
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 19-03-2026, 134 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
134 days early
2024
35 days early
2023
41 days early
2022
60 days early
2021
59 days early
2020
58 days early
2019
57 days early
← before the deadline after the deadline →
tick = median of all Belgian filings

This company filed its last 7 accounts on average 63 days before the deadline; the Belgian median for financial year 2024 is 4 days before the deadline, and 38% of all filings were late.

Searched, nothing found (1)
neutral · No strike-offs in the KBO publications
Searched since 2021.
KBO publications · our coverage
  1. Resignations & appointments · End &…Resignation: VANDENEEDE Diederik (director) ·…
  2. Registered officeRegistered-office move
  3. Annual accounts filedfinancial year 2025 · micro…

Financials · financial year 2025, micro format

Turnover
≈ €260,000
Estimated: probably between €170,000 and €440,000
Total assets
€14,973▼ 91.0%
2024 · €166,609
Net result
€82,111
2024 · -€262,349
Working capital
-€75,256▲ 66.2%
2024 · -€222,879
Trend over the years

2021 to 2025, 5 financial years 2018 to 2025, 8 financial years

The operating result returns to profit in 2025: €83,239 after a loss of €260,942 in 2024, the highest result in the available series.

What the company sold each financial year and what was left of it. A loss stands below the zero line.

Operating result€83,239 2025 Net result€82,111 2025

Use the arrow keys on the chart for the figures per year.

Every figure with its change against the financial year before
favourable unfavourable
Line20182019202020212022202320242025
Operating result€21,928-€44,415▲ 103%€42,197▼ 5.0%€27,226▼ 35.5%€20,032▼ 26.4%€36,457▲ 82.0%-€260,942€83,239
Net result€14,427-€32,428▲ 125%€28,259▼ 12.9%€17,172▼ 39.2%€13,133▼ 23.5%€24,952▲ 90.0%-€262,349€82,111
Equity€101,039-€103,467▲ 2.4%€81,725▼ 21.0%€78,897▼ 3.5%€92,030▲ 16.6%€104,982▲ 14.1%-€157,367-€75,256▲ 52.2%
Total assets€206,685-€199,485▼ 3.5%€178,604▼ 10.5%€152,980▼ 14.3%€170,243▲ 11.3%€165,385▼ 2.9%€166,609▲ 0.7%€14,973▼ 91.0%
Debt€105,646-€96,019▼ 9.1%€96,878▲ 0.9%€74,082▼ 23.5%€78,213▲ 5.6%€60,403▼ 22.8%€323,977▲ 436%€90,229▼ 72.1%
Working capital€62,410-€65,498▲ 4.9%€48,173▼ 26.5%€43,923▼ 8.8%€45,864▲ 4.4%€50,159▲ 9.4%-€222,879-€75,256▲ 66.2%
Turnover and EBIT margin not published: the micro format does not require them. The turnover shown is an estimate from the gross margin.
Key figures and ratios
2025 value · change against 2024
Solvency
-502.6%▼
2024 · -94.5%
Current ratio
0.17▼
2024 · 0.29
ROA
548.4%▲
2024 · -157.5%
Debt ≤ 1 year
€90,229▼
2024 · €315,496
Income taxes
€84▼
2024 · €192
No debt to equity: equity is negative, so debt divided by equity means nothing.
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Annual accounts
Filed annual accounts As filed with the NBB · 2025 against 2024 · 48 lines
Balance sheet Code20242025
Assets
Total assets20/58€166,609€14,973▼
Fixed assets21/28€73,992-
Tangible fixed assets22/27€71,869-
Land and buildings22€53,562-
Plant, machinery and equipment23€17,875-
Furniture and vehicles24€433-
Financial fixed assets28€2,124-
Current assets29/58€92,617€14,973▼
Stocks and contracts in progress3€51,841-
Stocks30/36€51,841-
Amounts receivable within one year40/41€38,976€5,078▼
Trade receivables40€31,168€5,078▼
Other amounts receivable41€7,808-
Cash at bank and in hand54/58€557€8,086▲
Deferred charges and accrued income490/1€1,244€1,809▲
Equity and liabilities
Total equity and liabilities10/49€166,609€14,973▼
Equity10/15-€157,367-€75,256▲
Contributions10/11€6,200€6,200=
Reserves13€98,782€98,782=
Tax-exempt reserves132€16,494€16,494=
Distributable reserves133€82,289€82,289=
Profit (loss) carried forward14-€262,349-€180,238▲
Amounts payable17/49€323,977€90,229▼
Amounts payable after more than one year17€8,481-
Financial debts170/4€8,481-
Amounts payable within one year42/48€315,496€90,229▼
Current portion of amounts payable after more than one year42€13,056-
Trade debts44€301,576€3,992▼
Suppliers440/4€301,576€3,992▼
Taxes, remuneration and social security45€505€1,715▲
Taxes450/3€505€1,715▲
Other amounts payable47/48€359€84,522▲
Income statement Code20242025
Non-recurring operating income76A-€181,884
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€18,047-
Other operating charges640/8€2,742€1,902▼
Non-recurring operating charges66A€283,914-
Gross operating margin9900€43,760€85,141▲
Operating profit (loss)9901-€260,942€83,239▲
Financial income75/76B€41-
Recurring financial income75€41-
Financial charges65/66B€1,256€1,044▼
Recurring financial charges65€1,256€1,044▼
Profit (loss) for the period before taxes9903-€262,157€82,195▲
Income taxes67/77€192€84▼
Profit (loss) for the period9904-€262,349€82,111▲
Profit (loss) for the period to be appropriated9905-€262,349€82,111▲
Appropriation of the result
Profit (loss) to be appropriated9906-€262,349-€180,238▲
Profit (loss) brought forward from the previous period14P--€262,349

The notes to these accounts (7 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Line20182019202020212022202320242025Change
Non-recurring operating income76A-----€10,895-€181,884-
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€13,739€13,316€14,102€16,528€19,619€17,303€18,047--
Other operating charges640/8---€2,549€2,441€2,707€2,742€1,902▼ 30.6%
Non-recurring operating charges66A----€1,115€1,205€283,914--
Gross operating margin9900€37,631€59,934€59,469€46,303€43,207€57,672€43,760€85,141▲ 94.6%
Operating profit (loss)9901€21,928€44,415€42,197€27,226€20,032€36,457-€260,942€83,239-
Financial income75/76B------€41--
Recurring financial income75-€78€25---€41--
Financial charges65/66B---€1,277€2,066€1,291€1,256€1,044▼ 16.9%
Recurring financial charges65€1,987€1,711€1,374€1,277€2,066€1,291€1,256€1,044▼ 16.9%
Profit (loss) for the period before taxes9903€19,940€42,782€40,848€25,949€17,966€35,166-€262,157€82,195-
Income taxes67/77€5,513€10,354€12,590€8,777€4,834€10,214€192€84▼ 56.3%
Profit (loss) for the period9904€14,427€32,428€28,259€17,172€13,133€24,952-€262,349€82,111-
Profit (loss) for the period to be appropriated9905€14,427€32,428€28,259€17,172€13,133€24,952-€262,349€82,111-
Line20182019202020212022202320242025Change
Assets
Total assets20/58€206,685€199,485€178,604€152,980€170,243€165,385€166,609€14,973▼ 91.0%
Fixed assets21/28€99,019€90,058€78,670€70,033€88,467€76,360€73,992--
Tangible fixed assets22/27€96,895€87,934€76,547€67,909€86,343€74,236€71,869--
Land and buildings22---€59,968€82,203€67,882€53,562--
Plant, machinery and equipment23---€3,390€3,535€4,242€17,875--
Furniture and vehicles24---€4,550€605€2,112€433--
Financial fixed assets28€2,124€2,124€2,124€2,124€2,124€2,124€2,124--
Current assets29/58€107,666€109,427€99,933€82,947€81,776€89,025€92,617€14,973▼ 83.8%
Stocks and contracts in progress3€44,277€45,900€42,197€54,386€53,845€55,767€51,841--
Stocks30/36---€54,386€53,845€55,767€51,841--
Amounts receivable within one year40/41€59,044€57,992€30,689€27,198€26,759€31,093€38,976€5,078▼ 87.0%
Trade receivables40---€25,975€20,593€31,093€31,168€5,078▼ 83.7%
Other amounts receivable41---€1,223€6,166-€7,808--
Cash at bank and in hand54/58€1,920€3,542€22,849---€557€8,086▲ 15×
Deferred charges and accrued income490/1---€1,363€1,173€2,166€1,244€1,809▲ 45.5%
Equity and liabilities
Total equity and liabilities10/49€206,685€199,485€178,604€152,980€170,243€165,385€166,609€14,973▼ 91.0%
Equity10/15€101,039€103,467€81,725€78,897€92,030€104,982-€157,367-€75,256▲ 52.2%
Contributions10/11€6,200€6,200-€6,200€6,200€6,200€6,200€6,200=
Reserves13€18,354€18,354€75,525€72,697€85,830€98,782€98,782€98,782=
Non-distributable reserves130/1---€1,860€1,860----
Reserves not available under the articles1311---€1,860€1,860----
Tax-exempt reserves132---€16,494€16,494€16,494€16,494€16,494=
Distributable reserves133---€54,344€67,476€82,289€82,289€82,289=
Profit (loss) carried forward14€76,485€78,913-----€262,349-€180,238▲ 31.3%
Amounts payable17/49€105,646€96,019€96,878€74,082€78,213€60,403€323,977€90,229▼ 72.1%
Amounts payable after more than one year17€60,390€52,090€43,645€35,058€42,300€21,537€8,481--
Financial debts170/4---€35,058€42,300€21,537€8,481--
Amounts payable within one year42/48€45,256€43,929€51,761€39,024€35,913€38,866€315,496€90,229▼ 71.4%
Current portion of amounts payable after more than one year42---€8,587€20,460€20,763€13,056--
Financial debts43---€254€1,703€335---
Credit institutions430/8---€254€1,703€335---
Trade debts44€22,639€14,633€17,255€18,312€11,954€10,446€301,576€3,992▼ 98.7%
Suppliers440/4---€18,312€11,954€10,446€301,576€3,992▼ 98.7%
Taxes, remuneration and social security45---€9,138€1,795€6,003€505€1,715▲ 240%
Taxes450/3---€9,138€1,795€6,003€505€1,715▲ 240%
Other amounts payable47/48---€2,733-€1,319€359€84,522▲ 236×
Line20182019202020212022202320242025Change
Profit (loss) for the period9904€14,427€32,428€28,259€17,172€13,133€24,952-€262,349€82,111-
+ Depreciation and write-downs630€13,739€13,316€14,102€16,528€19,619€17,303€18,047--
Operating cash flow (approximation)€28,166€45,744€42,361€33,700€32,752€42,255-€244,303€82,111-
Investment in fixed assets (approximation)--€4,356-€2,714-€7,890-€38,053-€5,196-€15,679--
Change in cash-€1,622€19,307----€7,529-

Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.

Download as CSV

Latest 10 of 24 filings with the National Bank
Financial year Type Filed Reference
31-12-2025 micro format 19-03-2026 2026-00058370
31-12-2024 micro format 26-06-2025 2025-00189943
31-12-2023 micro format 20-06-2024 2024-00156292
31-12-2022 micro format 01-06-2023 2023-00104228
31-12-2021 micro format 02-06-2022 2022-20044771
31-12-2020 micro format 03-06-2021 2021-17200215
31-12-2019 micro format 04-06-2020 2020-14800067
31-12-2018 micro format 29-05-2019 2019-15100218
31-12-2017 micro format 31-05-2018 2018-15000594
31-12-2016 micro format 08-06-2017 2017-15900199

Show all 24 filings

Public contracts: No European public contracts awarded found since October 2016. Contracts below the EU thresholds are not in TED.

Directors

Directors
no sitting director read yet, last change in 2026
No directors read yet: 3 of 4 Gazette acts processed. See the directors and other office holders in the KBO →

Mandate history

1 person since 2023, 0 in office
Show
  • Board
  • began earlier
Mandates per person, with start and end dates
Name Functions and periods
VANDENEEDE Diederik
  • Director, until 22-06-2023
  • Director (not named in the articles), from before 22-06-2023 to 13-08-2026
See the board, name and registered office on a given date →

Owners and capital

Capital and shareholders

Capital over the years
  1. 22-06-2023 Converted to unavailable equity

Group and network

Connections & network

No directors read yet: 3 of 4 Gazette acts processed.

History

The registered office was moved to Leefdaal in 2026.1 Total assets fell from €206,685 in 2018 to €14,973 in 2025.2 In 2026 EQUIPHARMA was dissolved and its liquidation closed in a single deed.3

  1. 1Belgian Official Gazette, 20-05-2026
  2. 2National Bank, annual accounts 2018 and 2025
  3. 3Belgian Official Gazette, 13-08-2026

Acts, filings and financial milestones

Next filing, financial year 2026, expected by 31-07-2027
2026
13-08
Gazette deed Resignations & appointments · End & cessation
Resignation: VANDENEEDE Diederik (director) · Net-asset statement · Auditor report20 facts ▸
  • General meeting, 06-08-2026
  • Other provision, “ontsluiting voorzitter voorlezing verslag bestuursorgaan, ontbinding” (deed in Dutch)
  • Net-asset statement, 06-05-2026
  • Other provision, “ontsluiting voorzitter voorlezing verslag bedrijfsrevisor, artikel 2:71 §2 WVV” (deed in Dutch)
  • Auditor report, “Oudenaarde”, EUR (deed in Dutch)
  • Other provision, “ontbinding en sluiting vereffening in één akte, artikel 2:80 WVV” (deed in Dutch)
  • Other provision, “datum van ondertekening controleverslag” (deed in Dutch)
  • Other provision, “vereffening deficitair, geen roerende voorheffing op liquidatiebonus” (deed in Dutch)
  • Other provision, “akkoord aandeelhouder en bestuurder, ontbinding en sluiting vereffening in één akte” (deed in Dutch)
  • Other provision, “laattijdige overhandiging stukken, geen wezenlijke invloed op controle” (deed in Dutch)
  • Other provision, “kennisgeving aandeelhouder, kopie verslagen ontvangen, geen opmerkingen” (deed in Dutch)
  • Dissolution, “ontbinding met dadelijke invereffeningstelling, artikel 2:80 WVV” (deed in Dutch)
  • +8 further facts in this act
20-05
Gazette deed Registered office
Registered-office move2 facts ▸
  • Board meeting, 28-11-2025
  • Registered-office move, Willem van Vlasselaerstraat 13 te 3061 Leefdaal
19-03
NBB filing Annual accounts filed
financial year 2025 · micro format
2025
31-12
Financial Back to profitnet €82,111
Net result €82,111 after one loss-making year.
26-06
NBB filing Annual accounts filed
financial year 2024 · micro format
2024
31-12
Financial Weakest financial yearnet -€262,349
Net result drops to -€262,349, the lowest in the series.
20-06
NBB filing Annual accounts filed
financial year 2023 · micro format
2023
31-12
Financial Equity above €100,000equity €104,982 ▲14.1%
A profit in every financial year since 2018 builds equity to €104,982.
22-06
Gazette deed Resignation: Vandeneede Diederik (director)
Reappointment: Vandeneede Diederik (director) · Amendment of the articles · Capital conversion10 facts ▸
  • General meeting, “buitengewone algemene vergadering” (deed in Dutch)
  • Amendment of the articles (2 times)
  • Capital conversion, “statutair onbeschikbare eigen vermogensrekening” (deed in Dutch)
  • Other provision, “vormen en meerderheden van statutenwijziging, beperking statutair onbeschikbare eigen vermogensrekening” (deed in Dutch)
  • Capital
  • Director resignation, Vandeneede Diederik (director)
  • Director reappointment, Vandeneede Diederik (director (not named in the articles))
  • Other provision, “kwijting ontslagnemende bestuurder voor uitoefening mandaat, algemene vergadering zal beslissen” (deed in Dutch)
  • Registered office clause, “1800 Vilvoorde,Mechelsestraat 17” (deed in Dutch)
  • Power of attorney, Notarisassociatie Lens. Abbeloos Notarissen
01-06
NBB filing Annual accounts filed
financial year 2022 · micro format
2022
02-06
NBB filing Annual accounts filed
financial year 2021 · micro format
2021
03-06
NBB filing Annual accounts filed
financial year 2020 · micro format
Show earlier events
2020
04-06
NBB filing Annual accounts filed
financial year 2019 · micro format
2019
29-05
NBB filing Annual accounts filed
financial year 2018 · micro format
2018
31-05
NBB filing Annual accounts filed
financial year 2017 · micro format
2017
08-06
NBB filing Annual accounts filed
financial year 2016 · micro format
Financial milestoneGazette deedNBB filingFinancial milestones sit on the financial year-end date, not the filing date.Of the 24 annual accounts filed, the latest 10 are here; all 24 are under Financials.
3 of 4 deeds read
About the unread acts

Of the 4 Belgian Official Gazette deeds we know for this company, 3 have been read. The other one has not been read yet: what they contain is neither established nor disproved here.

Have them read with priority Sign in to place this company at the front of the reading queue.
Inactive

Inactive since August 2026

EQUIPHARMA has not been in the KBO register since 12 August 2026.

Status
Inactiveout of the register since 12 August 2026
Last annual accounts
financial year to 31 December 2025
Last registered office
Willem Van Vlasselaerstraat 13, 3061 Leefdaal (Bertem)as published on 13 August 2026
Legal form
Private limited company
Active since
24 October 2001
Official KBO record

Environmental permits: No permit applications found in Flanders. Brussels and Wallonia do not publish the applicant.

Sites & property

Location & real-estate footprint
Registered office, Bertem
exact location from the address register On OpenStreetMap
Ground area
405 m²
Building footprint
95 m²
Building volume
660 m³
Parcel 24061D0018/00B002, Flanders · tallest building 10.1 m. Linked by address, not a title deed.
1 parcel
Flanders 1 (100%)
Cadastral parcel Region Area Buildings Height / floors
24061D0018/00B002 Flanders 405 m² 1 · 95 m² 10.1 m · 2
How the parcels are linked
Good to know
The parcel matches the address exactly.

Articles of association

What the company does

PurposeThe activities the company may carry out under its articles.
“De aankoop en verkoop van farmaceutische producten van schoonheidsproducten en aanverwante producten; De aankoop en verkoop van…” (deed in Dutch)
7 activities (deed in Dutch)
  1. De aankoop en verkoop van farmaceutische producten van schoonheidsproducten en aanverwante producten
  2. De aankoop en verkoop van dieetproducten en orthopedische schoenen zowel bij groot- als kleinhandel
  3. De uitbating van apotheken
  4. De studie,de adviesverlening,expertise,engineering en elke dienstverlening in het kader van de hiervoor beschreven activiteiten
  5. Zij kan alle mogelijke commerciële,industriële,financiële,roerende en onroerende verrichtingen stellen die direct of indirect verband houden met haar voorwerp of die van die aard zijn dat ze de verwezenlijking en ontwikkeling ervan bevorderen
  6. Deelnemen in alle vennootschappen,verenigingen en ondernemingen zowel in België als in het buitenland,bij wijze van inbreng,inschrijving,overdracht,deelneming,fusie,financiële tussenkomst of anderszins
  7. En tevens de functies van bestuurder en vereffenaar uitoefenen in andere vennootschappen

The full purpose is in the deed

DurationHow long the company exists; usually unlimited, so until it is dissolved.
Unlimited
Name clauseThe name the company operates under according to its articles.
EQUIPHARMA
Registered office clauseThe region of the registered office; it decides among other things the language of official documents.
“Vlaams Gewest, administratieve zetels,agentschappen,werkhuizen,stapelplaatsen,bijkantoren” (deed in Dutch)

deed of 22-06-2023

Who represents it, and how

Who signsWho may bind the company towards others, for example by signing a contract.
Each director alone
Board ruleHow the board is made up, meets and takes decisions.
“Met of zonder beperking van duur, 1” (deed in Dutch)
“Alle handelingen nodig of nuttig voor verwezenlijking voorwerp, wet of statuten aan algemene vergadering voorbehouden” (deed in Dutch)

deed of 22-06-2023

Meetings and financial year

Annual meetingWhen the shareholders meet each year, among other things to approve the annual accounts.
Third Saturday of June at 11:30

deed of 22-06-2023

Oversight and winding up

Dissolution ruleWhen and by whom the company can be dissolved.
“Vormen vereist voor statutenwijziging, ontbinding op elk moment door beslissing algemene vergadering” (deed in Dutch)
deed of 22-06-2023
Liquidation ruleHow assets are shared after dissolution: creditors first, then shareholders.
“Recht algemene vergadering om één of meerdere vereffenaars aan te duiden,bevoegdheden te omlijnen,vergoeding te bepalen, ontbinding om welke…” (deed in Dutch)
deed of 22-06-2023
Custody of recordsWhere the books and records are kept after liquidation, by law for at least five years.
“Bij de wet verplichte termijn” (deed in Dutch)
deed of 13-08-2026

Other provisionsOther rules from the articles that fall under none of the themes above.

Other provision: “Dagelijks bestuur, alleen of gezamenlijk zoals bestuursorgaan bepaalt” (deed in Dutch)
Other provision: “Drie jaar, toezicht op de vennootschap” (deed in Dutch)
Other provision: “Door vennootschap ter beschikking gesteld elektronisch communicatiemiddel, elektronische algemene vergadering-deelneming op afstand” (deed in Dutch)
Other provision: “Iedere aandeelhouder langs elektronische weg op afstand vóór vergadering, uitoefening stemrecht langs elektronische weg vóór algemene…” (deed in Dutch)
Other provision: “Vanaf mededeling oproeping, uitoefening recht schriftelijke vragen langs elektronische weg vóór AV” (deed in Dutch)
Other provision: “Toegang algemene vergadering, houder effecten op naam ingeschreven in register effecten op naam per categorie” (deed in Dutch)
Other provision: “Bestuurder,bij gebrek aanwezige aandeelhouder met meeste aandelen,bij pariteit oudste, zittingen-processen-verbaal” (deed in Dutch)
Other provision: “Elke aandeelhouder aan ieder ander persoon al dan niet aandeelhouder,door alle middelen van overdracht,schriftelijke volmacht om te…” (deed in Dutch)
Other provision: “Bestuursorgaan, verdaging algemene vergadering” (deed in Dutch)
Other provision: “Bestemming winst-reserves, elk aandeel gelijk aandeel in winstverdeling” (deed in Dutch)
Liquidation distribution: “Na aanzuivering schulden,lasten,kosten of consignatie nodige sommen, netto actief onder alle aandeelhouders naar verhouding aantal…” (deed in Dutch)
1 more provision in the deed, see the deed of 22-06-2023

deed of 22-06-2023